Neuropeptide Y Is Released from Human Mammary and Radial Vascular Biopsies and Is a Functional Modulator of Sympathetic Cotransmission

Abstract

The role of neuropeptide Y (NPY) as a modulator of the vasomotor responses mediated by sympathetic cotransmitters was examined by electrically evoking its release from the perivascular nerve terminals of second- to third-order human blood vessel biopsies and by studying the peptide-induced potentiation of the vasomotor responses evoked by exogenous adenosine 5′ triphosphate (ATP) and noradrenaline (NA). Electrical depolarization of nerve terminals in mammary vessels and radial artery biopsies elicited a rise in superfusate immunoreactive NPY (ir-NPY), which was chromatographically identical to a standard of human NPY (hNPY); a second peak was identified as oxidized hNPY. The amount released corresponds to 4–6% of the total NPY content in these vessels. Tissue extracts also revealed two peaks; hNPY accounted for 68–85% of the ir-NPY, while oxidized hNPY corresponded to 7–15%. The release process depended on extracellular calcium and on the frequency and duration of the electrical stimuli; guanethidine blocked the release, confirming the peptide’s sympathetic origin. Assessment of the functional activity of the oxidized product demonstrated that while it did not change basal tension, the NA-evoked contractions were potentiated to the same extent as with native hNPY. Moreover, NPY potentiated both the vasomotor action of ATP or NA alone and the vasoconstriction elicited by the simultaneous application of both cotransmitters. RT-PCR detected the mRNA coding for the NPY Y₁ receptor. In summary, the release of hNPY or its oxidized species, elicited by nerve terminal depolarization, coupled to the potentiation of the sympathetic cotransmitter vasomotor responses, highlights the modulator role of NPY in both arteries and veins, strongly suggesting its involvement in human vascular sympathetic reflexes.

NPY and Stress 30 Years Later: The Peripheral View

“…2). For example, studies using guinea pig vas deferens have shown that although ATP and NE are co-stored, the amount of ATP and NE within each vesicle may not be uniform and furthermore, that differential release of each vesicle is dependent on the intensity of stimulation by the SNS (Burnstock 1995; Ralevic 2009; Donoso et al 2004) (Fig. 2).…”

Denervation of gastroepiploic artery graft can reduce vasospasm

“…Many studies have investigated the vascular contraction of the blood vessel preparations using periarterial nerve stimulations. [13][14][15][16][17] However, we believe the present study is the first to investigate the vascular contraction of a blood vessel whose periarterial nerve was mechanically removed.…”

“…EFS is commonly performed for functional evaluation to assess PSN. [13][14][15][16][17] The strength of EFS is determined by voltage, frequency, Gastroepiploic artery contraction to high K þ at the beginning and end of the experiment. Contraction force in both groups was similar at the beginning and end of each experiment.…”

Simultaneous Silencing ofNpyandDbhExpression in Hindbrain A1/C1 Catecholamine Cells Suppresses Glucoprivic Feeding

“…Corelease induces vasoconstriction. When NPY and NE are administrated together in human vascular biopsies, NPY dramatically potentiates the NE-evoked vessel constriction through an NPY receptor-dependent mechanism (Donoso et al, 2004a,b; Huidobro-Toro and Donoso, 2004). In the supraoptic nucleus, substance P and NPY, coreleased by some catecholamine terminals in that site, differentially potentiate Epi-induced vasopressin and oxytocin secretion (Kapoor and Sladek, 2001).…”